摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl 4,4-difluoro-3-hydroxypiperidine-1-carboxylate | 1186688-52-7

中文名称
——
中文别名
——
英文名称
tert-butyl 4,4-difluoro-3-hydroxypiperidine-1-carboxylate
英文别名
4,4-difluoro-3-hydroxy-1-piperidine carboxylic acid tert-butyl ester;Tert-butyl 4,4-difluoro-3-hydroxypiperidine-1-carboxylate
tert-butyl 4,4-difluoro-3-hydroxypiperidine-1-carboxylate化学式
CAS
1186688-52-7
化学式
C10H17F2NO3
mdl
——
分子量
237.247
InChiKey
WMSNGRGUQYKMEF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    49.8
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    tert-butyl 4,4-difluoro-3-hydroxypiperidine-1-carboxylate盐酸 、 sodium hydride 、 三乙胺 作用下, 以 1,4-二氧六环乙醇二氯甲烷N,N-二甲基甲酰胺 、 mineral oil 为溶剂, 反应 12.0h, 生成 3-(2-(4,4-difluoro-3-hydroxypiperidine-1-carbonyl)-9-fluoro-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl)-4-(imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione
    参考文献:
    名称:
    [EN] 1H-PYRROLE-2,5-DIONE COMPOUNDS AND METHODS OF USING THEM TO INDUCE SELF-RENEWAL OF STEM/PROGENITOR SUPPORTING CELLS
    [FR] COMPOSÉS 1H-PYRROLE-2,5-DIONE ET LEURS PROCÉDÉS D'UTILISATION POUR INDUIRE UN AUTO-RENOUVELLEMENT DE CELLULES DE SUPPORT SOUCHES/PROGÉNITRICES
    摘要:
    本发明涉及1H-吡咯-2,5-二酮化合物以及利用它们诱导干/祖细胞支持细胞自我更新的方法,包括诱导干/祖细胞增殖,同时在子细胞中保持分化为组织细胞的能力。
    公开号:
    WO2018125746A1
  • 作为产物:
    描述:
    3-溴-4-氧代哌啶-1-羧酸苄酯盐酸二乙胺基三氟化硫 、 palladium on carbon 、 氢气 、 palladium(II) hydroxide 、 sodium hydride 、 potassium carbonate 作用下, 以 四氢呋喃二氯甲烷 、 mineral oil 为溶剂, -20.0~70.0 ℃ 、101.33 kPa 条件下, 反应 62.33h, 生成 tert-butyl 4,4-difluoro-3-hydroxypiperidine-1-carboxylate
    参考文献:
    名称:
    [EN] PYRIDAZINONE OR PYRIDINONE COMPOUNDS, PREPARATION METHODS AND USES THEREOF
    [FR] COMPOSÉS DE PYRIDAZINONE OU PYRIDINONE, LEURS PROCÉDÉS DE PRÉPARATION ET LEURS UTILISATIONS
    摘要:
    Provided herein are novel compounds, for example, compounds having a Formula (I), or a pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in treating cancer.
    公开号:
    WO2023020457A1
点击查看最新优质反应信息

文献信息

  • ALKYLAMINOPYRIDINE DERIVATIVE
    申请人:Ando Makoto
    公开号:US20110015181A1
    公开(公告)日:2011-01-20
    The present invention relates to a compound that is useful for treatment of, for example, hypertension, arteriosclerosis, bulimia and obesity because of having an antagonistic action to a neuropeptide Y receptor and is represented by formula (I) [wherein R 1 represents hydrogen, cyano, or the like; R represents a group represented by formula (II); X 1 represents C 1-4 lower alkylene or the like; X 2 represents lower alkylene or the like; and Het represents a 5-membered heteroaromatic ring that has at least one nitrogen atom and, in addition, one or two hetero atoms selected from the group consisting of nitrogen, sulfur and oxygen atoms] or to a pharmaceutically acceptable salt thereof.
    本发明涉及一种化合物,由式(I)表示,该化合物具有对神经肽Y受体的拮抗作用,因此可用于治疗高血压、动脉硬化、暴食症和肥胖症等疾病。其中,R1代表氢、氰或类似物;R代表由式(II)表示的基团;X1代表C1-4低烷基或类似物;X2代表低烷基或类似物;Het代表一个五元杂环芳香环,其中至少有一个氮原子,并且还有一个或两个来自氮、硫和氧原子组成的杂原子。该化合物或其药学上可接受的盐可用于治疗上述疾病。
  • [EN] ANTAGONISTS OF MRGX2<br/>[FR] ANTAGONISTES DE MRGX2
    申请人:GLAXOSMITHKLINE IP DEV LTD
    公开号:WO2022152852A1
    公开(公告)日:2022-07-21
    This application relates to compounds of Formula (I), which are antagonists of MrgX2 (Mas-related Gene X2) and thus are useful as therapeutic agents, specifically therapeutic agents for use in the treatment of chronic spontaneous urticaria, mastocytosis, cold urticaria, atopic dermatitis, rosacea, Crohns disease, ulcerative colitis, irritable bowel syndrome, rheumatoid arthritis, fibromyalgia, nasal polyps, neuropathic pain, inflammatory pain, chronic itch, drug-induced anaphlactoid reactions, metabolic syndrome, oesophagus reflux, asthma, cough, or migraine.
    本申请涉及式(I)的化合物,它们是MrgX2(Mas相关基因X2)的拮抗剂,因此可用作治疗剂,具体用于治疗慢性自发性荨麻疹、肥大细胞增多症、寒冷性荨麻疹、特应性皮炎、酒渣鼻、克隆病、溃疡性结肠炎、肠易激综合征、类风湿性关节炎、纤维肌痛、鼻息肉、神经痛、炎症性疼痛、慢性瘙痒、药物诱导的过敏反应、代谢综合征、食管反流、哮喘、咳嗽或偏头痛的治疗剂。
  • 1H-pyrrole-2,5-dione compounds and methods of using same
    申请人:Frequency Therapeutics, Inc.
    公开号:US11066419B2
    公开(公告)日:2021-07-20
    The present invention relates to 1H-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into tissue cells.
    本发明涉及 1H-吡咯-2,5-二酮化合物和使用它们诱导干/祖支持细胞自我更新的方法,包括诱导干/祖细胞增殖,同时保持子细胞分化成组织细胞的能力。
  • EP2264026
    申请人:——
    公开号:——
    公开(公告)日:——
  • 1H-PYRROLE-2,5-DIONE COMPOUNDS AND METHODS OF USING THEM TO INDUCE SELF-RENEWAL OF STEM/PROGENITOR SUPPORTING CELLS
    申请人:Frequency Therapeutics, Inc.
    公开号:US20190352313A1
    公开(公告)日:2019-11-21
    The present invention relates to 1H-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into tissue cells.
查看更多